Prof. Magnus von Knebel Doeberitz
Magnus von Knebel Doeberitz is Professor of Molecular Oncology and Medical Director of the Department of Applied Tumor Biology, Institute of Pathology of the University of Heidelberg. He is also head of the Clinical Cooperation Unit G105 of the German Cancer Research Center and is affiliated with the Molecular Medicine Partner Unit of the European Molecular Biology Laboratory (EMBL).
He served as founder and board member of several biotech companies, including mtmlabs (www.mtm-labs.com) that was acquired by Roche in 2011.
He spent his post doc in the laboratory of Nobel laureate Harald zur Hausen at the German Cancer Research Center. 1995 to 2001 he served as Professor of Molecular Oncology and Head of the Section of Molecular Diagnostics and Therapy in the Department of Surgery, University of Heidelberg. 2001 he was appointed as Medical Director of the Department of Applied Tumour Biology at the Institute of Pathology, University of Heidelberg
